US2008039451A1PendingUtilityA1
Use of thiazole derivatives for preparing a medicament intended to protect the mitochondria
Est. expiryJul 26, 2021(expired)· nominal 20-yr term from priority
A61P 39/02A61P 43/00A61P 39/00A61P 9/00A61P 9/04A61P 27/00A61P 25/00A61P 31/04A61P 27/16A61P 35/00A61P 25/28A61P 29/00A61P 27/02A61K 31/425A61P 13/12A61K 31/427A61K 31/426A61P 1/16A61K 31/54A61P 1/00A61P 21/00A61K 31/497
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of treating cirrhosis of the liver in warm-blooded animals comprising administering to warm-blooded in need thereof an effective amount of a compound of the formula where the substituents are as defined in the specification.
Claims
exact text as granted — not AI-modified1 . A method of treating cirrhosis of the liver in warm-blooded animals comprising administering to warm-blooded animals in need thereof an amount of a compound of the formula
in the form of a racemic mixture, of an enantiomer or of any combination of these forms, wherein:
A is
B is hydrogen;
R 1 and R 2 are independently selected from the group consisting of hydrogen and cycloalkyl;
R 3 and R 4 are independently hydrogen or alkyl, or R 3 and R 4 form together with the nitrogen atom which carries them a heterocycle containing in total 1 to 2 heteroatoms and 5 to 7 members, the missing members of which heterocycle are selected from the group consisting of —CHR 13 —, —NR 14 —, —O— and —S—, R 13 is selected from the group the group consisting of hydrogen —OH, alkyl and alkoxy and R 14 is selected from the group consisting of hydrogen. alkyl, —COR 15 , —COOR 15 and —CONR 16 R 17 , R 15 is alkyl and R 16 and R 17 are independently hydrogen or alkyl;
it being understood that alkoxy or alkyl, unless specified otherwise, has 1 to 6 carbon atoms and that cycloalkyl; unless specified otherwise, has 3 to 7 carbon atoms,
or a pharmaceutically acceptable salt thereof sufficient to treat cirrhosis.
2 - 6 . (canceled)
7 . The method of claim 1 , wherein the compounds are:
N-methyl[4-(10H-phenothiazin-2-yl)-1,3-thiazol-2-yl]methanamine; or 2,6-ditert-butyl-4-{2-[(4-methylpiperazin-1-yl)methyl]-1,3-thiazol4-yl}phenol; or a pharmaceutically acceptable salt thereof.
8 - 10 . (canceled)
11 . The method of claim 1 wherein B is selected from the group consisting of hydrogen, methyl and ethyl and R 1 and R 2 are independently hydrogen or alkyl.
12 . The method of claim 1 wherein B is hydrogen or methyl and one of R 1 and R 2 is hydrogen and the other is selected from the group consisting of hydrogen, alkyl and cycloalkyl.
13 . The method of claim 1 wherein B is hydrogen and of R 1 and R 2 is hydrogen and the other is hydrogen or alkyl of 1 to 3 carbon atoms.
14 . The method of claim 13 wherein one of R 1 and R 2 is hydrogen and the other is methyl.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.